Intravitreal triamcinolone and bevacizumab combination therapy for refractory choroidal neovascularization with retinal angiomatous proliferation

Eye

Volumn 22, Issue 7, 2008, Pages 978-980

  Bakri, S J ^a   Ekdawi, N S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE; VERTEPORFIN;

ABSENCE OF SIDE EFFECTS; AGED; CASE REPORT; DISEASE ASSOCIATION; DRUG RESPONSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LETTER; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; RETINA DETACHMENT; RETINA DISEASE; RETINA HEMORRHAGE; RETINA MACULA CYSTOID EDEMA; RETINAL ANGIOMATOUS PROLIFERATION; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION;

EID: 48049089130     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6703041     Document Type: Letter

References (5)

1. Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT et al. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Retina 2007; 27: 439-444.
2. Meyerle CB, Freund KB, Iturralde D, Spaide RF, Sorenson JA, Slakter JS et al. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 2007; 27: 451-457.
3. Augustin AJ, Schmidt-Erfurth U. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2006; 141: 638-645.
4. Nicole M, Ghiglione D, Lai S, Calabria G. Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1336-1338.
5. Costagliola C, Romano MR, dell'Omo R, Cipollone U, Polisena P. Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. Am J Ophthalmol 2007; 144(3): 449-451.